Is Paxmedica Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PXMD) stock is to Buy PXMD stock.
Out of 1 analyst, 0 (0%) are recommending PXMD as a Strong Buy, 1 (100%) are recommending PXMD as a Buy, 0 (0%) are recommending PXMD as a Hold, 0 (0%) are recommending PXMD as a Sell, and 0 (0%) are recommending PXMD as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year PXMD price target, the average PXMD price target is $3.00, with the highest PXMD stock price forecast at $3.00 and the lowest PXMD stock price forecast at $3.00.
The Wall Street analyst predicted that Paxmedica's share price could reach $3.00 by Dec 4, 2024. The average Paxmedica stock price prediction forecasts a potential upside of 275% from the current PXMD share price of $0.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.